u-91356 has been researched along with Dyskinesia, Drug-Induced in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bédard, PJ; Blanchet, PJ; Calon, F; Di Paolo, T; Goulet, M; Martel, JC; Piercey, MF | 1 |
Bédard, PJ; Blanchet, PJ; Calon, F; Di Paolo, T; Martel, JC; Piercey, MF; Walters, RR | 1 |
2 other study(ies) available for u-91356 and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aminoquinolines; Animals; Autoradiography; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Imidazoles; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA | 1995 |
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.
Topics: Aminoquinolines; Animals; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Imidazoles; Macaca fascicularis; Motor Activity; MPTP Poisoning; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1995 |